- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
North Chicago Today
By the People, for the People
CIBC Private Wealth Group LLC Increases Stake in AbbVie Inc.
The investment firm added over 13,000 shares of the pharmaceutical company to its portfolio in the third quarter.
Mar. 19, 2026 at 8:24am
Got story updates? Submit your updates here. ›
CIBC Private Wealth Group LLC raised its stake in AbbVie Inc. (NYSE:ABBV) by 1.1% during the 3rd quarter, according to a recent SEC filing. The fund now owns 1,179,751 shares of the company's stock, worth $273,159,000, after purchasing an additional 13,087 shares.
Why it matters
AbbVie is a major pharmaceutical company known for its blockbuster drugs like Humira. The increase in CIBC Private Wealth's stake suggests the firm sees continued growth potential in AbbVie's business and stock performance.
The details
CIBC Private Wealth Group LLC, an investment management firm, added to its existing position in AbbVie during the third quarter of 2025. The firm now owns over 1.17 million shares of the pharmaceutical company, representing a 1.1% increase from the prior quarter.
- CIBC Private Wealth Group LLC filed the 13F report disclosing the increased stake in AbbVie on March 19, 2026.
- The additional 13,087 shares were purchased during the third quarter of 2025.
The players
CIBC Private Wealth Group LLC
An investment management firm that manages over $200 billion in assets for high-net-worth individuals, institutions, and retirement plans.
AbbVie Inc.
A global biopharmaceutical company that develops and markets a variety of specialty medicines, including the blockbuster drug Humira.
The takeaway
The increased stake by CIBC Private Wealth Group in AbbVie suggests the firm sees continued growth potential in the pharmaceutical company's business and stock performance, despite some recent market volatility.
